Document Detail

Treatment with finasteride and prostate cancer survival.
MedLine Citation:
PMID:  23137166     Owner:  NLM     Status:  Publisher    
Abstract Objective. This study compared survival after diagnosis of prostate cancer (PC) in men previously treated with finasteride, in men previously treated with α-adrenoceptor antagonists, in men treated with both, and in men who had received neither type of medication. Material and methods. In total, 3791 men diagnosed with PC in northern Denmark were identified. The region's prescription database was used to identify all men prescribed finasteride and α-adrenoceptor antagonists and those who had received neither medication during the period 1989-2001. Among men with a diagnosis of PC, overall survival and disease-specific survival were assessed after diagnosis using Cox proportional hazards regression. The risk of being diagnosed with non-localized PC was estimated using conditional logistic regression. Results. The adjusted hazard ratio (HR) for PC death and overall death after treatment with finasteride was 0.93 [95% confidence interval (CI) 0.76-1.14] and 0.92 (95% CI 0.77-1.10), respectively. Treatment with α-adrenoceptor antagonists was associated with a reduced risk of PC death and overall death (HR 0.78, 95% CI 0.67-0.90, and 0.82, 95% CI 0.73-0.93, respectively. The risk of being diagnosed with non-localized PC was increased for men taking finasteride (odds ratio 1.14, 95% CI 1.01-1.29) per 100 defined daily doses. Conclusions. Treatment with finasteride prior to a diagnosis of PC did not affect PC-specific survival, but increased the risk of being diagnosed with non-localized disease. Treatment with α-adrenoceptor antagonists was associated with better cause-specific survival and lower risk of non-localized disease.
Anders Kjellman; Søren Friis; Fredrik Granath; Ove Gustafsson; Henrik Toft Sørensen; Olof Akre
Related Documents :
9215226 - Leukemia risk and occupational electric field exposure in los angeles county, california.
3381836 - Adenocarcinoma of the stomach and exposure to occupational dust.
25048246 - Vitamin a intake and risk of melanoma: a meta-analysis.
18655106 - Maternal nickel exposure and congenital musculoskeletal defects.
22068726 - A comparison of levels of select minerals in scalp hair samples with estimated dietary ...
16860186 - Impact of comorbidities on mortality in managed care patients with ckd.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Scandinavian journal of urology and nephrology     Volume:  -     ISSN:  1651-2065     ISO Abbreviation:  Scand. J. Urol. Nephrol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0114501     Medline TA:  Scand J Urol Nephrol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Clinical Science, Intervention, and Technology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolon...
Next Document:  Zinc therapy improves deleterious effects of chronic copper administration on mice testes: histopath...